Consequently, based on the previous report by Sherwood et al., we expanded the metabolic investigation of the consequences of WNT5A signaling in two metastatic breast cancer cell lines (MDA-MB-468 and MDA-MB-231) in the present study. This evidence concerns the gene WNT5A and breast carcinoma.